Novel 99mTc labeled complexes with bisphosphonate isocyanide: Radiosynthesis and evaluation as potential bone-seeking agents

Bioorg Med Chem Lett. 2022 Oct 1:73:128918. doi: 10.1016/j.bmcl.2022.128918. Epub 2022 Aug 1.

Abstract

In order to develop 99mTc-labeled complexes with bisphosphonate isocyanide as novel bone imaging agents, two bisphosphonate isocyanide derivatives (CNALN and CNPAM) were synthesized and radiolabeling was performed for preparing the corresponding [99mTc]Tc(I) complexes. [99mTc]Tc-CNALN and [99mTc]Tc-CNPAM were obtained with high radiochemical purity and showed good in vitro stability. Both of them were hydrophilic and had high affinity to hydroxyapatite. The biodistribution studies in mice revealed [99mTc]Tc-CNALN showed higher bone/background ratios at 60 min post-injection. In single photon emission computed tomography (SPECT) imaging study, [99mTc]Tc-CNALN had an obvious accumulation in bone, suggesting it would be a promising bone-seeking agent.

Keywords: Alendronate; Bone imaging; Isocyanide; Pamidronate; Technetium-99m.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyanides
  • Diphosphonates* / chemistry
  • Mice
  • Organotechnetium Compounds* / chemistry
  • Radiopharmaceuticals / pharmacology
  • Technetium / chemistry
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon / methods

Substances

  • Cyanides
  • Diphosphonates
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • Technetium